In vitro diagnostic devices are enabling earlier intervention and paving the way for important strides in patient care and treatment. Point-of-care tests rapidly produce results on site and are one of the fastest-growing segments in medtech, while the emerging field of genomic screening can help assess a patient's risk for disease even before symptoms are present.
By learning how to navigate the FDA's pathways to market and working with the right contract partners, you'll leap through regulatory hoops and deliver your end product faster than the competition.
Point-Of-Care Market Opportunities and Key Issues
The Journey to Develop Novel Point-Of-Care Diagnostics
In response to attendee demand for more IVD suppliers, meet with these exhibitors and others in the IVD Zone. A dedicated on the expo floor, connect with top industry players who are driving the technology forward.